Component
Mouse insulin response to aspartame
Context-specific entity; species, compartment and exposure are stated on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The study reported increased insulin secretion with 0.15% aspartame in mice and monkeys.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Animal feeding experiments.
- limitations
- Exact duration and systemic dose not supplied by accessed abstract; do not infer ordinary human intake.
- nutrient_topic
- Aspartame collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Aspartame
- plain_language
- A neural or hormonal route can differ from metabolite toxicity.
- primary_references
- Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39978336/ · DOI 10.1016/j.cmet.2025.01.006
Aspartame: digestion, taste, metabolite dependencies and experimental signaling (2026-09-20) · lines 242–248
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Animal feeding experiments. · source_derived_draft · unverified_draft
## aspartame-animal-insulin A neural or hormonal route can differ from metabolite toxicity. The study reported increased insulin secretion with 0.15% aspartame in mice and monkeys. Model: Animal feeding experiments. Limitations: Exact duration and systemic dose not supplied by accessed abstract; do not infer ordinary human intake. Evidence access: Primary abstract Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39978336/ · DOI 10.1016/j.cmet.2025.01.006
Complete structured claim and evidenceSubdiaphragmatic vagotomy abolished the aspartame-associated insulin rise in the reported experiment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Animal surgical perturbation in the feeding study.
- limitations
- Does not uniquely identify the initial sweet receptor.
- nutrient_topic
- Aspartame collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Aspartame
- plain_language
- Interrupting the nerve route interrupted the hormone response.
- primary_references
- Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39978336/ · DOI 10.1016/j.cmet.2025.01.006
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Aspartame: digestion, taste, metabolite dependencies and experimental signaling (2026-09-20) · lines 250–256
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Animal surgical perturbation in the feeding study. · source_derived_draft · unverified_draft
## aspartame-vagotomy-gate Interrupting the nerve route interrupted the hormone response. Subdiaphragmatic vagotomy abolished the aspartame-associated insulin rise in the reported experiment. Model: Animal surgical perturbation in the feeding study. Limitations: Does not uniquely identify the initial sweet receptor. Evidence access: Primary abstract Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39978336/ · DOI 10.1016/j.cmet.2025.01.006
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.